Australia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines
Asia PacificAustralia's CSL unable to simultaneously make Novavax, AstraZeneca vaccines Reuters 3 minute read CSL Ltd (CSL.AX) said on Thursday it does not have the capacity to simultaneously produce AstraZeneca (AZN.L) and Novavax Inc's (NVAX.O) COVID-19 vaccines after a local report said the U.S.-based firm was looking for an Australian manufacturing partner. Australian biotech CSL is already under contract to locally make 50 million doses of the AstraZeneca vaccine, and is currently churning out more than a million doses a week. read more Australia is relying on deliveries from Pfizer (P...